Clinical Trial Update: High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a cardio-oncology consultation intervention to reduce cardiovascular risk in prostate cancer patients after ARPI therapy (Hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Prostate Cancer (Diagnosis), Prostate Cancer Stage IV | Phase 2 | Status: NOT_YET_RECRUITING